Role of advanced imaging techniques in the evaluation of oncological therapies in patients with colorectal liver metastases

被引:0
|
作者
Martina Caruso [1 ]
Arnaldo Stanzione [1 ]
Anna Prinster [2 ]
Laura Micol Pizzuti [2 ]
Arturo Brunetti [1 ]
Simone Maurea [1 ]
Pier Paolo Mainenti [2 ]
机构
[1] Department of Advanced Biomedical Sciences, University of Naples "Federico II"
[2] Institute of Biostructures and Bioimaging, National Research Council
关键词
D O I
暂无
中图分类号
R735.34 [];
学科分类号
100214 ;
摘要
In patients with colorectal liver metastasis(CRLMs) unsuitable for surgery, oncological treatments, such as chemotherapy and targeted agents, can be performed. Cross-sectional imaging [computed tomography(CT), magnetic resonance imaging(MRI), 18-fluorodexoyglucose positron emission tomography with CT/MRI] evaluates the response of CRLMs to therapy, using post-treatment lesion shrinkage as a qualitative imaging parameter. This point is critical because the risk of toxicity induced by oncological treatments is not always balanced by an effective response to them. Consequently, there is a pressing need to define biomarkers that can predict treatment responses and estimate the likelihood of drug resistance in individual patients. Advanced quantitative imaging(diffusionweighted imaging, perfusion imaging, molecular imaging) allows the in vivo evaluation of specific biological tissue features described as quantitative parameters. Furthermore, radiomics can represent large amounts of numerical and statistical information buried inside cross-sectional images as quantitative parameters. As a result, parametric analysis(PA) translates the numerical data contained in the voxels of each image into quantitative parameters representative of peculiar neoplastic features such as perfusion, structural heterogeneity, cellularity, oxygenation, and glucose consumption. PA could be a potentially useful imaging marker for predicting CRLMs treatment response. This review describes the role of PA applied to cross-sectional imaging in predicting the response to oncological therapies in patients with CRLMs.
引用
收藏
页码:521 / 535
页数:15
相关论文
共 50 条
  • [21] The Role of Preoperative Chemotherapy in Patients with Resectable Colorectal Liver Metastases
    Benoist, Stephane
    Nordlinger, Bernard
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (09) : 2385 - 2390
  • [22] The role of surgery in the treatment of liver metastases for colorectal cancer patients
    Harms, J
    Obst, T
    Thorban, S
    Busch, R
    Fink, U
    Heidecke, CD
    Roder, JD
    Siewert, JR
    HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2321 - 2328
  • [23] The Role of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
    Ayez, N.
    Grunhagen, D. J.
    De Jonge, J.
    Ijzermans, J. N.
    Eggermont, A. M.
    Verhoef, C.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S35 - S35
  • [24] The Role of Preoperative Chemotherapy in Patients with Resectable Colorectal Liver Metastases
    Stéphane Benoist
    Bernard Nordlinger
    Annals of Surgical Oncology, 2009, 16 : 2385 - 2390
  • [25] Treatment for advanced colorectal liver metastases in the era of chemotherapy - Role of hepatectomy in treating multiple bilobar colorectal cancer metastases
    Nojiri, Kazunori
    Tanaka, Kuniya
    Takeda, Kazuhisa
    Sugita, Mitsutaka
    Ueda, Michio
    Matsuyama, Ryusei
    Taniguchi, Kouichi
    Kumamoto, Takafumi
    Mori, Ryutaro
    Watanabe, Jun
    Ota, Mitsuyoshi
    Ichikawa, Yasushi
    Endo, Itaru
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 : S69 - S69
  • [26] The Role of Liver Resection for Patients with Liver and Unresectable Lung Colorectal Metastases (LUNA)
    Tahsin M. Khan
    Emily A. Verbus
    Shahyan U. Rehman
    Yun Shin Chun
    Jonathan M. Hernandez
    Annals of Surgical Oncology, 2021, 28 : 4102 - 4103
  • [27] The Role of Liver Resection for Patients with Liver and Unresectable Lung Colorectal Metastases (LUNA)
    Khan, Tahsin M.
    Verbus, Emily A.
    Rehman, Shahyan U.
    Chun, Yun Shin
    Hernandez, Jonathan M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (08) : 4102 - 4103
  • [28] Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases
    Nancy Kemeny
    Ieva Kurilova
    Jia Li
    Juan C. Camacho
    Constantinos T. Sofocleous
    CardioVascular and Interventional Radiology, 2019, 42 : 1240 - 1254
  • [29] Liver-Directed and Systemic Therapies for Colorectal Cancer Liver Metastases
    Kemeny, Nancy
    Kurilova, Ieva
    Li, Jia
    Camacho, Juan C.
    Sofocleous, Constantinos T.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2019, 42 (09) : 1240 - 1254
  • [30] Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases
    Karim, Salma
    Seidensticker, Ricarda
    Seidensticker, Max
    Ricke, Jens
    Schinner, Regina
    Treitl, Karla
    Ruebenthaler, Johannes
    Ingenerf, Maria
    Schmid-Tannwald, Christine
    RADIOLOGY AND ONCOLOGY, 2024, 58 (01) : 33 - 42